Highlights
ASX: KZA       KAZIA THERAPEUTICS LIMITED
Last Price Today's Change   Day's Range   Trading Volume
0.365   -0.01 (2.67%)  0.365 - 0.375  13,618

Overview

 
Avg Volume (4 weeks):18,538
4 Weeks Range:0.365 - 0.46
4 Weeks Price Volatility (%):
0.00%
52 Weeks Range:0.33 - 0.62
52 Weeks Price Volatility (%):
12.07%
Average Price Target:-

Headlines



No recent Headlines for this stock.


Business Background

Kazia Therapeutics Limited, formerly Novogen Limited, is an oncology biotechnology company, which is focused on developing cancer treatments. The Company is primarily engaged in pharmaceutical research and development. It has two drug technology platforms (the Superbenzopyran (SBP) technology and Anti-tropomyosin (ATM)) yielding various drug candidates across a range of oncology indications. The Company's product candidates include Cantrixil (TRX-E-002-1), Anisina (ATM-3507) and Trilexium (TRX-E-009-1). The Company's target indication for Cantrixil is ovarian cancer, and Diffuse Intrinsic Pontine Glioma (DIPG) for Trilexium. The initial target pediatric indication for Anisina is neuroblastoma. Cantrixil is the lead development candidate arising from its SBP technology. Anisina is an approach to chemotherapy that targets the cancer cells' actin cytoskeleton. Trilexium (TRX-E-009-1) is its second lead SBP drug candidate.

  Be the first to like this.
 


 

630  589  704  9250 

ActiveGainersLosers
Top 10 Active Counters
 NameLastChange 
 CLI 0.05+0.005 
 CLA 0.064+0.006 
 BLK 0.0090.00 
 AVZ 0.059+0.003 
 AMP 2.11-0.13 
 IMU 0.015-0.001 
 TLS 3.87+0.03 
 OEL 0.0480.00 
 BLY 0.006+0.001 
 S32 3.31+0.09 
Partners & Brokers